Irrisept Antimicrobial Wound Lavage contains low concentration chlorhexidine gluconate (CHG) 0.05% in sterile water for irrigation.
Our Medical Affairs team is focused on building clinical evidence, researching new products, and offering clinical support to its customers.
Irrimax Corporation is focused on preventing infections, reducing healthcare costs and improving patient outcomes.
We are committed to building clinical evidence to support the safety and effectiveness of our products. Our goal is to become a recognized leader in medical products for wound irrigation, cleansing and debridement.
The low-concentration CHG used in Irrisept acts as a preservative and maintains product sterility throughout the product life cycle. Irrisept uses CHG in its pure form diluted in an FDA-registered GMP manufacturing site where the amount of CHG in the solution is tightly controlled and scientifically validated. The Irrisept product is aseptically filled and the sterility of the product is controlled during manufacturing.
© 2022 Irrimax Corporation. All Rights Reserved.
Irrimax®, Irrisept®, Irririnse®, Irriprobe® and Splatterguard® (all regardless of letter case) are registered trademarks of Innovation Technologies, Inc., parent company of Irrimax Corporation.
